CD34 and cancer: NK cells, which can be used for NK cell-based immunotherapy in cases of cancer, can be differentiated from stem cells from several sources like peripheral blood cells (PBCs), umbilical cord blood (UCB), embryonic stem cells (ESCs), CD34+ hematopoietic stem cells (HSCs), and induced pluripotent stem cells (iPSCs) [18].